Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M298Revenue $M89.6Net Margin (%)7.2Z-Score3.4
Enterprise Value $M291EPS $0.2Operating Margin %10.3F-Score5
P/E(ttm))48.1Cash Flow Per Share $-0.5Pre-tax Margin (%)11.6Higher ROA y-yY
Price/Book5.010-y EBITDA Growth Rate %0Quick Ratio1.5Cash flow > EarningsN
Price/Sales3.25-y EBITDA Growth Rate %0Current Ratio2.3Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %14.8ROA % (ttm)4.7Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)11.0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M42.5ROI % (ttm)9.1Gross Margin Increase y-yN

Gurus Latest Trades with SCMP

Number of guru portfolios checked: 54.

No Entry found!

SCMP is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


SCMP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Dolecek Gayle RDirector 2014-03-18Sell1,200$8.03-13.33 view
Claiborne Cary JCFO 2014-02-27Sell2,500$9-22.67 view
Dolecek Gayle RDirector 2014-02-18Sell9,067$8.04-13.43 view
Ueno RyujiCEO, Chief Scientific Officer, 10% Owner 2014-01-17Sell360,000$10.36-32.82 view
Kuno Sachiko10% Owner 2014-01-17Sell360,000$10.36-32.82 view
S&R Technology Holdings, LLC10% Owner 2014-01-17Sell360,000$10.36-32.82 view
Dolecek Gayle RDirector 2014-01-13Sell9,066$9.21-24.43 view
Claiborne Cary JCFO 2014-01-07Sell2,500$9-22.67 view
Kuno Sachiko10% Owner 2013-10-16Sell360,000$6.359.61 view
Ueno RyujiCEO, Chief Scientific Officer, 10% Owner 2013-10-16Sell360,000$6.359.61 view

Press Releases about SCMP :

    Quarterly/Annual Reports about SCMP:

    News about SCMP:

    Articles On GuruFocus.com
    Weekly CEO Sells Highlight: VeriFone Systems Inc, Northeast Utilities, Sucampo Pharmaceuticals Inc, Jan 26 2014 
    Weekly CEO Sells Highlight: Sucampo Pharmaceuticals Inc, Family Dollar Stores Inc, Nike Inc, Hallibu Oct 21 2013 
    comment on SCMP Mar 06 2013 
    Sucampo Pharmaceuticals Inc. Reports Operating Results (10-K) Mar 08 2011 
    Sucampo Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 03 2010 
    Sucampo Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 05 2010 
    Sucampo Pharmaceuticals Inc. Reports Operating Results (10-Q) May 10 2010 
    Sucampo Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 06 2009 
    Sucampo Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 07 2009 
    Sucampo Pharmaceuticals Reports Financial Results for the Second Quarter of 2009 Aug 06 2009 

    More From Our Partners
    Dynavax Starts Phase III Study on Heplisav-B - Analyst Blog Apr 16 2014 - ZACKS

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Hide